WuXi Biologics (Cayman) Inc (WXXWY)
3.73
+0.03
(+0.81%)
USD |
OTCM |
May 16, 16:00
WuXi Biologics Accounts Receivable (Quarterly): 797.57M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 797.57M |
| June 30, 2023 | 669.40M |
| June 30, 2023 | 669.40M |
| December 31, 2022 | 674.08M |
| June 30, 2022 | 808.43M |
| June 30, 2022 | 808.43M |
| December 31, 2021 | 490.07M |
| June 30, 2021 | 440.49M |
| June 30, 2021 | 440.49M |
| December 31, 2020 | 357.05M |
| June 30, 2020 | 234.33M |
| Date | Value |
|---|---|
| June 30, 2020 | 234.33M |
| December 31, 2019 | 190.75M |
| June 30, 2019 | 126.62M |
| June 30, 2019 | 126.62M |
| December 31, 2018 | 110.90M |
| June 30, 2018 | 87.00M |
| June 30, 2018 | 87.00M |
| December 31, 2017 | 44.40M |
| June 30, 2017 | 28.76M |
| June 30, 2017 | 28.76M |
| December 31, 2016 | 32.18M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
126.62M
Minimum
Jun 2019
808.43M
Maximum
Jun 2022
471.20M
Average
440.49M
Median
Jun 2021
Accounts Receivable (Quarterly) Benchmarks
| Wuxi AppTec Co Ltd | 979.27M |
| Sinovac Biotech Ltd | 426.01M |
| CASI Pharmaceuticals Inc | 9.551M |
| Zai Lab Ltd | 60.42M |
| Gracell Biotechnologies Inc (DELISTED) | -- |